Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Soper

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Obstetrics and Gynecology|November 1, 1994
Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasiaG C Rodriguez, C L Hughes, J T Soper, et al.
Gynecologic Oncology|December 2, 2006
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patientsJ T Soper, M Spillman, J H Sampson, et al.
American Journal of Clinical Oncology|February 1, 1990
Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology GroupH B Muss, J A Blessing, K D Hatch, et al.
Obstetrics and Gynecology|May 1, 1989
Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptorE M Segreti, D B Novotny, J T Soper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgeryG C Rodriguez, J T Soper, A Berchuck, et al.
Obstetrics and Gynecology|December 1, 1994
Evaluation of prognostic factors and staging in gestational trophoblastic tumorJ T Soper, A C Evans, M R Conaway, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
p53 overexpression in advanced-stage endometrial adenocarcinomaM F Kohler, P Carney, R Dodge, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
American Journal of Obstetrics and Gynecology|January 11, 1991
Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage diseaseA Berchuck, G Rodriguez, R B Kinney, et al.
American Journal of Obstetrics and Gynecology|February 11, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancerA Berchuck, G C Rodriguez, A Kamel, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Obstetrics and Gynecology|November 1, 1994
Serum progesterone for the exclusion of early pregnancy in women at risk for recurrent gestational trophoblastic neoplasiaG C Rodriguez, C L Hughes, J T Soper, et al.
Gynecologic Oncology|December 2, 2006
High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patientsJ T Soper, M Spillman, J H Sampson, et al.
American Journal of Clinical Oncology|February 1, 1990
Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology GroupH B Muss, J A Blessing, K D Hatch, et al.
Obstetrics and Gynecology|May 1, 1989
Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptorE M Segreti, D B Novotny, J T Soper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy, and surgeryG C Rodriguez, J T Soper, A Berchuck, et al.
Obstetrics and Gynecology|December 1, 1994
Evaluation of prognostic factors and staging in gestational trophoblastic tumorJ T Soper, A C Evans, M R Conaway, et al.
American Journal of Obstetrics and Gynecology|November 1, 1996
p53 overexpression in advanced-stage endometrial adenocarcinomaM F Kohler, P Carney, R Dodge, et al.
American Journal of Obstetrics and Gynecology|October 1, 1990
The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionV J Hunter, L Daly, M Helms, et al.
American Journal of Obstetrics and Gynecology|January 11, 1991
Overexpression of HER-2/neu in endometrial cancer is associated with advanced stage diseaseA Berchuck, G Rodriguez, R B Kinney, et al.
American Journal of Obstetrics and Gynecology|February 11, 1991
Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. Correlation of receptor expression with prognostic factors in patients with ovarian cancerA Berchuck, G C Rodriguez, A Kamel, et al.
Pageof 13